DeepCyte
PrivateLast Round
Seed
Apr 9, 2026
Total Funding Raised
$1.5M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
DeepCyte is a techbio company that combines single-cell metabolomics with AI models to detect and predict drug toxicity early for the biopharma industry.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical AI, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
DeepCyte Comparables
Compare DeepCyte with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Axiom Bio | 87% | |
| Ignota Labs | 79% | |
| VeriSIM Life | 74% | |
DeepCyte Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Apr 9, 2026 |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 9, 2026
$2M raised in Seed round.
DeepCyte Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about DeepCyte's valuation, stock price, and market status.